Loading...
High-Dose CD20-Targeted Radioimmunotherapy-Based Autologous Transplantation Improves Outcomes for Persistent Mantle Cell Lymphoma
Autologous stem cell transplant (ASCT) can improve outcomes for mantle cell lymphoma (MCL) patients, yet relapses are frequent. We hypothesized that high-dose anti-CD20 radioimmunotherapy (RIT)-based conditioning could improve results in this setting. We thus assessed 162 consecutive patients with M...
Na minha lista:
| Udgivet i: | Br J Haematol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4715476/ https://ncbi.nlm.nih.gov/pubmed/26455717 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.13773 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|